Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January–June 2020)

Mohammed Al-Qahtani; Martin Behe; Guy Bormans; Giuseppe Carlucci; Jean Dasilva; Clemens Decristoforo; Philip H. Elsinga; Klaus Kopka; Xiang-Guo Li; Robert Mach; Oskar Middel; Jan Passchier; Marianne Patt; Ivan Penuelas; Ana Rey; Peter J. H. Scott; Sergio Todde; Jun Toyohara; Danielle Vugts

doi:https://doi.org/10.1186/s41181-020-00118-5

Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January–June 2020)

Mohammed Al-Qahtani, Martin Behe, Guy Bormans, Giuseppe Carlucci, Jean Dasilva, Clemens Decristoforo, Philip H. Elsinga, Klaus Kopka, Xiang-Guo Li, Robert Mach, Oskar Middel, Jan Passchier, Marianne Patt, Ivan Penuelas, Ana Rey, Peter J. H. Scott, Sergio Todde, Jun Toyohara, Danielle Vugts

Research output: Contribution to journal › Review article › Academic › peer-review

Abstract

Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to describe trends in the field. Results: This commentary of highlights has resulted in 19 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.

Original language	English
Article number	5
Journal	EJNMMI radiopharmacy and chemistry
Volume	6
Issue number	1
DOIs	https://doi.org/10.1186/s41181-020-00118-5
Publication status	Published - 1 Dec 2021

Access to Document

https://doi.org/10.1186/s41181-020-00118-5

Cite this

Al-Qahtani, M., Behe, M., Bormans, G., Carlucci, G., Dasilva, J., Decristoforo, C., Elsinga, P. H., Kopka, K., Li, X.-G., Mach, R., Middel, O., Passchier, J., Patt, M., Penuelas, I., Rey, A., Scott, P. J. H., Todde, S., Toyohara, J., & Vugts, D. (2021). Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January–June 2020). EJNMMI radiopharmacy and chemistry, 6(1), Article 5. https://doi.org/10.1186/s41181-020-00118-5

@article{8b2c25f25de6453fad381863155a6164,

title = "Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January–June 2020)",

abstract = "Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to describe trends in the field. Results: This commentary of highlights has resulted in 19 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.",

author = "Mohammed Al-Qahtani and Martin Behe and Guy Bormans and Giuseppe Carlucci and Jean Dasilva and Clemens Decristoforo and Elsinga, {Philip H.} and Klaus Kopka and Xiang-Guo Li and Robert Mach and Oskar Middel and Jan Passchier and Marianne Patt and Ivan Penuelas and Ana Rey and Scott, {Peter J. H.} and Sergio Todde and Jun Toyohara and Danielle Vugts",

year = "2021",

month = dec,

day = "1",

doi = "https://doi.org/10.1186/s41181-020-00118-5",

language = "English",

volume = "6",

journal = "EJNMMI radiopharmacy and chemistry",

issn = "2365-421X",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "1",

}

Al-Qahtani, M, Behe, M, Bormans, G, Carlucci, G, Dasilva, J, Decristoforo, C, Elsinga, PH, Kopka, K, Li, X-G, Mach, R, Middel, O, Passchier, J, Patt, M, Penuelas, I, Rey, A, Scott, PJH, Todde, S, Toyohara, J & Vugts, D 2021, 'Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January–June 2020)', EJNMMI radiopharmacy and chemistry, vol. 6, no. 1, 5. https://doi.org/10.1186/s41181-020-00118-5

TY - JOUR

T1 - Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January–June 2020)

AU - Al-Qahtani, Mohammed

AU - Behe, Martin

AU - Bormans, Guy

AU - Carlucci, Giuseppe

AU - Dasilva, Jean

AU - Decristoforo, Clemens

AU - Elsinga, Philip H.

AU - Kopka, Klaus

AU - Li, Xiang-Guo

AU - Mach, Robert

AU - Middel, Oskar

AU - Passchier, Jan

AU - Patt, Marianne

AU - Penuelas, Ivan

AU - Rey, Ana

AU - Scott, Peter J. H.

AU - Todde, Sergio

AU - Toyohara, Jun

AU - Vugts, Danielle

PY - 2021/12/1

Y1 - 2021/12/1

N2 - Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to describe trends in the field. Results: This commentary of highlights has resulted in 19 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.

AB - Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to describe trends in the field. Results: This commentary of highlights has resulted in 19 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85130765229&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/33507426

U2 - https://doi.org/10.1186/s41181-020-00118-5

DO - https://doi.org/10.1186/s41181-020-00118-5

M3 - Review article

C2 - 33507426

SN - 2365-421X

VL - 6

JO - EJNMMI radiopharmacy and chemistry

JF - EJNMMI radiopharmacy and chemistry

IS - 1

M1 - 5

ER -

Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January–June 2020)

Abstract

Access to Document

Other files and links

Cite this